[Federal Register Volume 71, Number 89 (Tuesday, May 9, 2006)]
[Notices]
[Page 26970]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-7020]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Committee on Heritable Disorders and Genetic Diseases in 
Newborns and Children; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:

    Name: Advisory Committee on Heritable Disorders and Genetic 
Diseases in Newborns and Children (ACHDGDNC).
    Dates and Times: June 5, 2006, 9 a.m. to 5 p.m. June 6, 2006, 
8:30 a.m. to 3 p.m.
    Place: Four Points Sheraton Downtown, Franklin AB Room, 1201 K 
Street, NW., Washington, DC 20005.
    Status: The meeting will be open to the public with attendance 
limited to space availability.
    Purpose: The Advisory Committee provides advice and 
recommendations concerning the grants and projects authorized under 
the Heritable Disorders Program and technical information to develop 
policies and priorities for this program. The Heritable Disorders 
Program was established to enhance the ability of State and local 
health agencies to provide for newborn and child screening, 
counseling and health care services for newborns and children having 
or at risk for heritable disorders. The Committee was established 
specifically to advise and guide the Secretary regarding the most 
appropriate application of universal newborn screening tests, 
technologies, policies, guidelines and programs for effectively 
reducing morbidity and mortality in newborns and children having or 
at risk for heritable disorders.
    Agenda: The meeting will be devoted to the decision making 
process for candidate conditions on the Newborn Screening Panel as 
well as the continued work and reports by the Committee's 
subcommittees on laboratory standards and procedures, follow-up 
treatment, education and training.
    Proposed agenda items are subject to change.
    Time will be provided each day for public comment. Individuals 
who wish to provide public comment or who plan to attend the meeting 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the ACHDGDNC 
Executive Secretary, Michele A. Lloyd-Puryear, M.D., Ph.D. (contact 
information provided below).
    Contact Person: Anyone interested in obtaining a roster of 
members or other relevant information should write or contact 
Michele A. Lloyd-Puryear, M.D., Ph.D., Maternal and Child Health 
Bureau, Health Resources and Services Administration, Room 18A-19, 
Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857, 
Telephone (301) 443-1080. Information on the Advisory Committee is 
available at http://mchb.hrsa.gov/programs/genetics/committee.

    Dated: May 3, 2006.
Tina M. Cheatham,
Director, Division of Policy Review and Coordination.
[FR Doc. E6-7020 Filed 5-8-06; 8:45 am]
BILLING CODE 4165-15-P